Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

Summary

Phase II trial to study the effectiveness of homoharringtonine in treating patients who have chronic phase chronic myelogenous leukemia. Drugs used in chemotherapy, such as homoharringtonine, work in different ways to stop cancer cells from dividing so they stop growing or die

Timeline

Start

1999-11

Primary completion

2005-09

Completion

—

Drugs

Indications